All Stories

  1. Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months
  2. Challenges of developing and conducting an international study of resilience in migrant adolescents
  3. Long-Term Outcomes of Hyperglycemic Preterm Infants Randomized to Tight Glycemic Control
  4. Bayley-III motor scale and neurological examination at 2 years do not predict motor skills at 4.5 years
  5. Pre-school screening for developmental and emotional health: Comparison with neurodevelopmental assessment
  6. Outcome at 2 Years after Dextrose Gel Treatment for Neonatal Hypoglycemia: Follow-Up of a Randomized Trial
  7. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes
  8. Neurobehavior of Neonates Born to Mothers Receiving Opioid Maintenance Treatment
  9. Prenatal exposure to recreational drugs affects global motion perception in preschool children
  10. Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years
  11. Global motion perception is independent from contrast sensitivity for coherent motion direction discrimination and visual acuity in 4.5-year-old children
  12. Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study
  13. A New Zealand pilot randomized controlled trial of a web-based interactive self-management programme (MSInvigor8) with and without email support for the treatment of multiple sclerosis fatigue
  14. Changes in resting EEG following methadone treatment in opiate addicts
  15. Exploratory study of bed-sharing and maternal-infant bonding
  16. Body composition in offspring of New Zealand women: ethnic and gender differences at age 1–3 years in 2005–2009
  17. Methadone Maintenance Treatment and Cognitive Function: A Systematic Review
  18. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3years
  19. Neurodevelopmental and Body Composition Outcomes in Children With Congenital Hypothyroidism Treated With High-Dose Initial Replacement and Close Monitoring
  20. Maternal methadone dose during pregnancy and infant clinical outcome
  21. Response to Wouldes and Woodward: Maternal methadone dose during pregnancy and infant clinical outcome
  22. Cross-national Comparison of Prenatal Methamphetamine Exposure on Infant and Early Child Physical Growth: A Natural Experiment
  23. Auditory evoked arousal responses of 3-month-old infants exposed to methamphetaminein utero: a nap study
  24. Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand
  25. Predictors of Inadequate Prenatal Care in Methamphetamine-Using Mothers in New Zealand and the United States
  26. Response to Comments on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279-2284
  27. Using Stochastic modelling to identify unusual continuous glucose monitor measurements and behaviour, in newborn infants
  28. A qualitative investigation of first-episode psychosis in adolescents
  29. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand
  30. Maternal methadone dose during pregnancy and infant clinical outcome
  31. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students
  32. Depression in Older People: Visual Impairment and Subjective Ratings of Health
  33. The effect of methadone treatment on the quantity and quality of human fetal movement
  34. A qualitative study of filicide by mentally ill mothers
  35. A relativistic model of a charged oscillator in a magnetic field and its application